Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 9/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28411727 | 0.93 | ACHE (0.40) | ACHEEPHX1NAAACA12CA1 | |
| SCHEMBL16870483 | 0.87 | ACHE (0.37) | ACHEEPHX1TSHR | |
| SCHEMBL25616153 | 0.85 | ACHE (0.38) | ACHEEPHX1NAAACA12CA1 | |
| SCHEMBL16866707 | 0.84 | ACHE (0.35) | ACHEEPHX1CA12CA1CA2 | |
| SCHEMBL15158163 | 0.80 | L3MBTL1 (0.38) | ACHEEPHX1TSHR | |
| SCHEMBL31539134 | 0.78 | EPHX1 (0.45) | ACHEEPHX1TSHR | |
| SCHEMBL181033 | 0.78 | EPHX1 (0.45) | ACHEEPHX1TSHR | |
| SCHEMBL3714955 | 0.77 | CA1 (0.39) | ACHEEPHX1CA1CA2 | |
| SCHEMBL25616501 | 0.76 | DGKA (0.38) | ACHEEPHX1NAAA | |
| SCHEMBL28891385 | 0.76 | ACHE (0.43) | ACHEEPHX1NAAACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2810957-A1 | Nitrile rubbers coupled with bisdihydropyrazole groups, production and use of the same | LANXESS Deutschland GmbH (DE) | 2014-12-10 | — | — | EP | disclosed |
| EP-2810956-A1 | Nitrile rubbers coupled with bisdihydropyrazole groups, production and use of the same | LANXESS Deutschland GmbH (DE) | 2014-12-10 | — | — | EP | disclosed |
| US-20140357801-A1 | Nitrile rubbers coupled via bisdihydropyrazole groups, production thereof and use thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357801-A1 | Nitrile rubbers coupled via bisdihydropyrazole groups, production thereof and use thereof | CYP2E1, NOS3, NOS2 | ACHE 1194/4885EPHX1 206/4885NAAA 507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.